Glucagon-like peptide-1 represents a compelling development in our management field. Originally developed to manage blood sugar issues, this class of drugs have shown considerable ability to promote fat loss and aid body health . Experts actively exploring their potential in treating being overweight in patients lacking diabetes . GLP-3 Receptor